These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

540 related items for PubMed ID: 12412158

  • 41. Gene expression profiles of primary breast carcinomas from patients at high risk for local recurrence after breast-conserving therapy.
    Kreike B, Halfwerk H, Kristel P, Glas A, Peterse H, Bartelink H, van de Vijver MJ.
    Clin Cancer Res; 2006 Oct 01; 12(19):5705-12. PubMed ID: 17020974
    [Abstract] [Full Text] [Related]

  • 42. Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: twelve-year observations concerning lobular carcinoma in situ.
    Fisher ER, Land SR, Fisher B, Mamounas E, Gilarski L, Wolmark N.
    Cancer; 2004 Jan 15; 100(2):238-44. PubMed ID: 14716756
    [Abstract] [Full Text] [Related]

  • 43. The prognosis of patients with local recurrence more than five years after breast conservation therapy for invasive breast carcinoma.
    van der Sangen MJ, van de Poll-Franse LV, Roumen RM, Rutten HJ, Coebergh JW, Vreugdenhil G, Voogd AC.
    Eur J Surg Oncol; 2006 Feb 15; 32(1):34-8. PubMed ID: 16305821
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. The Yale University experience of early-stage invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC) treated with breast conservation treatment (BCT): analysis of clinical-pathologic features, long-term outcomes, and molecular expression of COX-2, Bcl-2, and p53 as a function of histology.
    Moran MS, Yang Q, Haffty BG.
    Breast J; 2009 Feb 15; 15(6):571-8. PubMed ID: 19995377
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study.
    Benitez PR, Streeter O, Vicini F, Mehta V, Quiet C, Kuske R, Hayes MK, Arthur D, Kuerer H, Freedman G, Keisch M, Dipetrillo T, Khan D, Hudes R.
    Am J Surg; 2006 Oct 15; 192(4):427-33. PubMed ID: 16978943
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Similar long-term results of breast-conservation treatment for Stage I and II invasive lobular carcinoma compared with invasive ductal carcinoma of the breast: The University of Pennsylvania experience.
    Santiago RJ, Harris EE, Qin L, Hwang WT, Solin LJ.
    Cancer; 2005 Jun 15; 103(12):2447-54. PubMed ID: 15887223
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Clinical-pathologic features and long-term outcomes of tubular carcinoma of the breast compared with invasive ductal carcinoma treated with breast conservation therapy.
    Liu GF, Yang Q, Haffty BG, Moran MS.
    Int J Radiat Oncol Biol Phys; 2009 Dec 01; 75(5):1304-8. PubMed ID: 19386432
    [Abstract] [Full Text] [Related]

  • 58. Pattern of local recurrence after conservative surgery and whole-breast irradiation.
    Freedman GM, Anderson PR, Hanlon AL, Eisenberg DF, Nicolaou N.
    Int J Radiat Oncol Biol Phys; 2005 Apr 01; 61(5):1328-36. PubMed ID: 15817334
    [Abstract] [Full Text] [Related]

  • 59. Relationship of tumor grade to other pathologic features and to treatment outcome of patients with early stage breast carcinoma treated with breast-conserving therapy.
    Nixon AJ, Schnitt SJ, Gelman R, Gage I, Bornstein B, Hetelekidis S, Recht A, Silver B, Harris JR, Connolly JL.
    Cancer; 1996 Oct 01; 78(7):1426-31. PubMed ID: 8839547
    [Abstract] [Full Text] [Related]

  • 60. Repeating conservative surgery after ipsilateral breast tumor reappearance: criteria for selecting the best candidates.
    Gentilini O, Botteri E, Veronesi P, Sangalli C, Del Castillo A, Ballardini B, Galimberti V, Rietjens M, Colleoni M, Luini A, Veronesi U.
    Ann Surg Oncol; 2012 Nov 01; 19(12):3771-6. PubMed ID: 22618719
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.